| Name | GRK5-IN-4 |
|---|
| Description | GRK5-IN-4 (Compound 16d, CCG-265328) is a potent and and selective covalent GRK5 (G protein-coupled receptor kinase 5) inhibitor, with an IC50 of 1.1 μM. GRK5-IN-4 shows 90-fold selectivity over GRK2. GRK5-IN-4 can be used for heart failure research[1]. |
|---|---|
| Related Catalog | |
| Target |
IC50: 1.1 ± 0.4 μM (GRK5), 1.8 ± 2 μM (GRK6), >100 μM (GRK2)[1] |
| In Vitro | GRK5-IN-4 (Compound 16d) (0-4 h) displays a marked increase in apparent potency as a function of time[1]. |
| References |
| Molecular Formula | C26H25N7O3 |
|---|---|
| Molecular Weight | 483.52 |